IL87172A - Method of isolating highly purified tissue factor inhibitor - Google Patents

Method of isolating highly purified tissue factor inhibitor

Info

Publication number
IL87172A
IL87172A IL8717288A IL8717288A IL87172A IL 87172 A IL87172 A IL 87172A IL 8717288 A IL8717288 A IL 8717288A IL 8717288 A IL8717288 A IL 8717288A IL 87172 A IL87172 A IL 87172A
Authority
IL
Israel
Prior art keywords
tfi
factor
column
activity
purified
Prior art date
Application number
IL8717288A
Other languages
English (en)
Other versions
IL87172A0 (en
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22137642&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL87172(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Washington filed Critical Univ Washington
Publication of IL87172A0 publication Critical patent/IL87172A0/xx
Publication of IL87172A publication Critical patent/IL87172A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/38—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL8717288A 1987-07-23 1988-07-21 Method of isolating highly purified tissue factor inhibitor IL87172A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7736687A 1987-07-23 1987-07-23

Publications (2)

Publication Number Publication Date
IL87172A0 IL87172A0 (en) 1988-12-30
IL87172A true IL87172A (en) 1994-12-29

Family

ID=22137642

Family Applications (1)

Application Number Title Priority Date Filing Date
IL8717288A IL87172A (en) 1987-07-23 1988-07-21 Method of isolating highly purified tissue factor inhibitor

Country Status (14)

Country Link
US (3) US6534276B1 (no)
EP (1) EP0300988A3 (no)
JP (1) JP2781391B2 (no)
KR (1) KR900007261B1 (no)
AU (1) AU604138B2 (no)
BR (1) BR1100464A (no)
CA (1) CA1338122C (no)
DK (1) DK174522B1 (no)
FI (1) FI97298C (no)
IL (1) IL87172A (no)
NO (1) NO174776C (no)
NZ (1) NZ225534A (no)
PT (1) PT88075B (no)
ZA (2) ZA885371B (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL87171A (en) * 1987-11-23 1995-08-31 Monsanto Co cDNA of human tissue factor inhibitor
DK408089D0 (da) * 1989-08-18 1989-08-18 Novo Nordisk As Proteiner
US5378614A (en) * 1989-08-18 1995-01-03 Novo Nordisk A/S Vector and method for making tissue factor pathway inhibitor (TFPI) analogues in yeast
CA2049873C (en) * 1990-08-27 2001-12-04 Tze-Chein Wun Anticoagulant combination of laci and sulfated polysaccharides
DK261490D0 (da) * 1990-10-31 1990-10-31 Novo Nordisk As New pharmaceutical compound
US5346991A (en) * 1991-06-13 1994-09-13 Genentech, Inc. Tissue factor mutants useful for the treatment of myocardial infarction and coagulopathic disorders
US5276015A (en) * 1992-03-18 1994-01-04 Washington University Method of inhibiting microvascular thrombosis
US6057287A (en) 1994-01-11 2000-05-02 Dyax Corp. Kallikrein-binding "Kunitz domain" proteins and analogues thereof
KR100443572B1 (ko) * 2002-05-29 2004-08-09 광양청매실농원영농조합법인 매실 농축액 제조방법
PT2298278E (pt) 2002-06-07 2016-02-25 Dyax Corp Prevenção e redução da perda de sangue e resposta inflamatória
US7153829B2 (en) 2002-06-07 2006-12-26 Dyax Corp. Kallikrein-inhibitor therapies
US7235530B2 (en) 2004-09-27 2007-06-26 Dyax Corporation Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
EP1981519B1 (en) 2005-12-29 2017-12-27 Dyax Corp. Protease inhibition
WO2007092607A2 (en) * 2006-02-09 2007-08-16 Genetech, Inc. Treatment of hemorrhagic viral infections using a tissue factor inhibitor
WO2009026334A2 (en) * 2007-08-21 2009-02-26 Genzyme Corporation Treatment with kallikrein inhibitors
CA2705486C (en) * 2007-11-19 2019-04-02 Celera Corporation Lung cancer markers and uses thereof
JP2013516389A (ja) 2009-01-06 2013-05-13 ダイアックス コーポレーション カリクレイン阻害剤による粘膜炎治療
ES2905545T3 (es) 2010-01-06 2022-04-11 Takeda Pharmaceuticals Co Proteínas de unión a calicreína plasmática
KR102011156B1 (ko) 2011-01-06 2019-08-16 다이액스 코포레이션 혈장 칼리크레인 결합 단백질
IL247942B (en) 2014-03-27 2022-09-01 Dyax Corp Compositions and methods for drops in macular edema as a result of diabetes
US11286307B2 (en) 2015-12-11 2022-03-29 Takeda Pharmaceutical Company Limited Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack
AU2021209045A1 (en) 2020-01-13 2022-07-28 Takeda Pharmaceutical Company Limited Plasma kallikrein inhibitors and uses thereof for treating pediatric hereditary angioedema attack

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE81149B1 (en) * 1987-02-12 2000-05-03 Genentech Inc Methods and deoxyribonucleic acid for the preparation of tissue factor protein
US5223427A (en) * 1987-03-31 1993-06-29 The Scripps Research Institute Hybridomas producing monoclonal antibodies reactive with human tissue-factor glycoprotein heavy chain
EP0321526A1 (en) * 1987-06-12 1989-06-28 Mount Sinai School Of Medicine Of The City University Of New York Cloning and expression of human tissue factor
US4966852A (en) * 1987-07-23 1990-10-30 Monsanto Company DNA clone of human tissue factor inhibitor

Also Published As

Publication number Publication date
ZA885371B (en) 1989-04-26
DK174522B1 (da) 2003-05-12
US6534276B1 (en) 2003-03-18
DK413588A (da) 1989-01-24
KR900007261B1 (en) 1990-10-06
ZA885370B (en) 1989-10-25
FI883477L (fi) 1989-01-24
US20040265981A1 (en) 2004-12-30
KR890001581A (ko) 1989-03-27
NZ225534A (en) 1991-02-26
US20030166194A1 (en) 2003-09-04
DK413588D0 (da) 1988-07-22
US6806360B2 (en) 2004-10-19
NO174776B (no) 1994-03-28
EP0300988A2 (en) 1989-01-25
FI97298B (fi) 1996-08-15
PT88075B (pt) 1995-06-30
JPS6447799A (en) 1989-02-22
BR1100464A (pt) 2000-02-08
CA1338122C (en) 1996-03-05
AU604138B2 (en) 1990-12-06
NO883271L (no) 1989-01-24
FI883477A0 (fi) 1988-07-22
IL87172A0 (en) 1988-12-30
US7060805B2 (en) 2006-06-13
FI97298C (fi) 1996-11-25
NO174776C (no) 1994-07-06
NO883271D0 (no) 1988-07-22
JP2781391B2 (ja) 1998-07-30
AU1928688A (en) 1989-02-02
PT88075A (pt) 1989-07-31
EP0300988A3 (en) 1990-04-11

Similar Documents

Publication Publication Date Title
CA1338122C (en) Tissue factor inhibitor of coagulation
Broze Jr et al. Isolation of the tissue factor inhibitor produced by HepG2 hepatoma cells.
US5466783A (en) Human tissue factor inhibitor
US4245051A (en) Human serum plasminogen activator
JP3122127B2 (ja) 抗凝血タンパク質
EP0197901B1 (en) Biologically active fragments of the human antihemophilic factor and method for their preparation and pharmaceutical preparations
AU2002218306A1 (en) Von willebrand factor (vWF) cleaving protease polypeptide, nucleic acid encoding the polypeptide and use of polypeptide
EP0182372A2 (en) New factor VIII coagulant polypeptides
JPH01165383A (ja) ヒト組織因子抑制因子のｄｎａクローン
JPH0443638B2 (no)
EP0439442B1 (en) Factor x-laci hybrid protein
JPH08500833A (ja) 凝血性蛋白質に特異的な抗体、未変性蛋白質を単離するためのそれらの利用、その蛋白質の蛋白質分解性開裂産物を含まない凝血性組成物
US4886876A (en) Factor VIII coagulant polypeptides
JPH0780915B2 (ja) ヒト−マクロファージ遊走阻止因子に対するモノクローナル抗体
Franco et al. Synthesis and apparent secretion of prothymosin alpha by different subpopulations of calf and rat thymocytes
DE3486023T2 (de) Verfahren zur herstellung von urokinase zymogen.
JPH08510212A (ja) 鉤虫抗凝固剤
He et al. Rabbit plasma, unlike its human counterpart, contains no complex between protein S and C4b-binding protein
EP0380443A2 (en) Monoclonal antibodies specific for thrombin hirudin
JP3022984B2 (ja) 細菌コラゲナーゼ遺伝子
Mezina et al. Isolation of milk-clotting enzyme from transgenic sheep milk and its comparison with calf chymosin
EP0354408A1 (en) Anti-urokinase monoclonal antibodies
JPH11508449A (ja) 組換えヒト前立腺特異的抗原およびその使用
IE911285A1 (en) Monoclonal antibodies against PP4, processes for the¹preparation thereof and the use thereof
Aronson et al. Human prothrombin fragments FI (αβ) and F2: Preparation and characterization of structural and biological properties

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired